Mehta A - Search Results

1

Salivary protein kinase C alpha and novel microRNAs as diagnostic and therapeutic resistance markers for oral squamous cell carcinoma in Indian cohorts.

Saproo S, Sarkar SS, Gautam V, Konyak CW, Dass G, Karmakar A, Sharma M, Ahuja G, Gupta A, Tayal J, Mehta A, Naidu S. Saproo S, et al. Among authors: mehta a. Front Mol Biosci. 2023 Jan 10;9:1106963. doi: 10.3389/fmolb.2022.1106963. eCollection 2022. Front Mol Biosci. 2023. PMID: 36703917 Free PMC article.

2

A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery.

Doval DC, Radhakrishna S, Tripathi R, Kashinath RI, Talwar V, Batra U, Mullapudi NA, Kumar K, Dewan AK, Chaturvedi H, Tayal J, Mehta A, Gupta S, Nimmagadda RBV. Doval DC, et al. Among authors: mehta a. Sci Rep. 2020 Apr 3;10(1):5886. doi: 10.1038/s41598-020-62618-3. Sci Rep. 2020. PMID: 32246015 Free PMC article.

3

EML4-ALK Fusion as a Resistance Mechanism to Osimertinib and Its Successful Management With Osimertinib and Alectinib: Case Report and Review of the Literature.

Batra U, Sharma M, Amrith BP, Mehta A, Jain P. Batra U, et al. Among authors: mehta a. Clin Lung Cancer. 2020 Nov;21(6):e597-e600. doi: 10.1016/j.cllc.2020.05.016. Epub 2020 May 23. Clin Lung Cancer. 2020. PMID: 32620470 Review. No abstract available.

4

Next generation sequencing for detection of EGFR alterations in NSCLC: is more better?

Batra U, Nathany S, Sharma M, Jain P, Mehta A. Batra U, et al. Among authors: mehta a. J Clin Pathol. 2022 Mar;75(3):164-167. doi: 10.1136/jclinpath-2020-207212. Epub 2020 Dec 28. J Clin Pathol. 2022. PMID: 33372105

5

EGFR and PDL1: A Match (Not) Made in Heaven-A Real-World Retrospective Analysis of PDL1 Expression in EGFR-Mutated NSCLC.

Batra U, Sharma M, Nathany S, Bansal A, Pasricha S, Jain P, Mehta A, Singh H. Batra U, et al. Among authors: mehta a. Adv Ther. 2021 Apr;38(4):1791-1800. doi: 10.1007/s12325-021-01655-4. Epub 2021 Feb 27. Adv Ther. 2021. PMID: 33641057

6

Malfeasance of KRAS mutations in carcinogenesis.

Tripathi R, Nathany S, Mehta A, Batra U, Mattoo S, Sharma M. Tripathi R, et al. Among authors: mehta a. Clin Exp Med. 2021 Aug;21(3):439-445. doi: 10.1007/s10238-021-00694-z. Epub 2021 Mar 12. Clin Exp Med. 2021. PMID: 33709341

7

IHC versus FISH versus NGS to detect ALK gene rearrangement in NSCLC: all questions answered?

Batra U, Nathany S, Sharma M, Pasricha S, Bansal A, Jain P, Mehta A. Batra U, et al. Among authors: mehta a. J Clin Pathol. 2022 Jun;75(6):405-409. doi: 10.1136/jclinpath-2021-207408. Epub 2021 Mar 22. J Clin Pathol. 2022. PMID: 33753563

8

Are all ALK variants created equal? Clinicopathologic features and outcomes: a propensity-matched study.

Batra U, Sharma M, Nathany S, Jain P, Soni S, Mehta A. Batra U, et al. Among authors: mehta a. Int J Clin Oncol. 2021 Jul;26(7):1221-1228. doi: 10.1007/s10147-021-01916-w. Epub 2021 Apr 12. Int J Clin Oncol. 2021. PMID: 33844110

9

Successful Treatment of EGFR-Mutant Synchronous SCLC and Lung Adenocarcinoma With Osimertinib.

Batra U, Nathany S, Sharma M, Mehta A, Jain P, Bansal A. Batra U, et al. Among authors: mehta a. JTO Clin Res Rep. 2020 Sep 12;2(1):100098. doi: 10.1016/j.jtocrr.2020.100098. eCollection 2021 Jan. JTO Clin Res Rep. 2020. PMID: 34589969 Free PMC article. No abstract available.

10

EGFR detection by liquid biopsy: ripe for clinical usage.

Batra U, Nathany S, Sharma M, Jain P, Dhanda S, Singh H, Jain A, Mehta A. Batra U, et al. Among authors: mehta a. Future Oncol. 2022 Jan;18(1):85-92. doi: 10.2217/fon-2021-0620. Epub 2021 Oct 27. Future Oncol. 2022. PMID: 34704813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,872 results

Search Page

Filters